Life Sciences/Biotech

Covisiint, AT&T, Microsoft Create National Health Info Portal

DETROIT - Covisint and AT&T are taking their health information sharing portal nationwide with the help of Microsoft Corp.'s HealthVault. Covisint, a subsidiary of Compuware, and AT&T first announced a statewide health information sharing system for the state of Tennessee earlier this year. Now, they?ve added Microsoft HealthVault, a platform for storing and accessing personal

By |2008-06-24T00:00:00-04:00June 24th, 2008|Archive, Life Sciences/Biotech|

Ernst & Young’s Beyond Borders: Global Biotechnology Report 2008

BOSTON - The global biotechnology industry reached record levels in financing and deal making in 2007, with more than $29.9 billion in financing raised within the industry, a new study from Ernst & Young reports. In the study, Beyond Borders: Global Biotechnology Report 2008, Ernst & Young examines three key trends that are transforming business

By |2008-06-17T00:00:00-04:00June 17th, 2008|Archive, Life Sciences/Biotech|

QuatRx Reports Success On Phase 3 Trails For Postmenopausal Pill

ANN ARBOR - QuatRx Pharmaceuticals on Monday announced detailed primary endpoint results from Phase 3 clinical trial of Ophena (ospemifene tablets) to treat postmenopausal women with symptoms of vulvovaginal atrophy, a common condition associated with menopause. The successful trial brings QuatRx once step closer to commercialization. The study, the company said, successfully met all four

By |2008-06-16T00:00:00-04:00June 16th, 2008|Archive, Life Sciences/Biotech|

U-M Life Sciences Institute Creates $10 Million Commercialization Fund

ANN ARBOR - The University of Michigan's Life Sciences Institute is launching a $10 million fund to shepherd promising biomedical discoveries from the lab bench to the marketplace, what biomedical researchers and venture capitalists call the Valley of Death. Called the Innovation Partnership, it uses philanthropic gifts to bridge this critical funding gap. More than

By |2008-06-10T00:00:00-04:00June 10th, 2008|Archive, Life Sciences/Biotech|

Former GlaxoSmithKline Exec Joins NanoBio’s Board

ANN ARBOR - Biopharmaceutical company NanoBio Corporation has appointed David Stout, former president of Pharmaceutical Operations for GlaxoSmithKline Pharmaceuticals, to its board of directors. �??We are pleased to welcome David to our Board of Directors and look forward to benefiting from his guidance and contributions,�?� said James Baker Jr., M.D., chairman of NanoBio Corporation. �??David�??s

By |2008-05-29T00:00:00-04:00May 29th, 2008|Archive, Life Sciences/Biotech|

Perrigo Cuts Deal For Generic Topical Products With Pentech

ALLEGAN - Perrigo Company has entered into a collaborative agreement with Cobrek Pharmaceuticals, a newly formed entity of Pentech Pharmaceuticals Inc., a privately owned company that specializes in the research and development of niche generic dosage forms. Pentech will contribute its ANDA filing for a generic equivalent to Luxiq(R) foam, a $34 million branded pharmaceutical

By |2008-05-21T00:00:00-04:00May 21st, 2008|Archive, Life Sciences/Biotech|

U-M Geriatrics Director Wins National Award

ANN ARBOR - Jeffrey Halter, M.D., director of the University of Michigan Geriatrics Center and Institute of Gerontology, has been named the 2008 Nascher/Manning Award recipient of the American Geriatrics Society �?? given to an individual with distinguished, life-long achievement in clinical geriatrics. Halter was cited by the AGS Board of Directors and the Awards

By |2008-05-06T00:00:00-04:00May 6th, 2008|Archive, Life Sciences/Biotech|